$0.00
(+0.00%
) Quote details
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$529.61M
Market Cap
-
P/E Ratio
-3.53
EPS
$12.34
52 Week High
$2.23
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Emeryville, California, dedicated to pioneering advanced therapeutics using its proprietary adeno-associated virus (AAV) vector platform. The company is at the forefront of addressing critical unmet medical needs in ophthalmology, neurology, and rare diseases, with a strong focus on transforming patient outcomes through innovative gene therapies. With a well-developed pipeline and strategic collaborations, 4D Molecular Therapeutics is strategically positioned to lead advancements in the biotherapeutics sector, aiming to bring novel treatments to market and establish itself as a prominent player in the field.
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD
BYND
WGRX
VHAI
YYAI
F
ASST
INTC
DVLT
CGBS
NVDA
BITF
TSLA
AAL
DNN
RGTI
NEUP
ADTX
PLUG
T
RIG
SCNX
NOK
AMD
QBTS
RF
CAN
LAES
SOFI
NEHC
GRAB
TLRY
QS
ADAP
SNAP
CIFR
AIRE
JOBY
RXRX
BAC
NIO
IREN
BTBT
RR
AMC
NVTS
PLTR
CLOV
UUUU
DFLI
RVPH
MARA
KDLY
APLD
PBR
WU
GOOGL
SOUN
IONQ
VZ
PFE
WULF
LAZR
SKYQ
MU
JBLU
SMCI
CLSK
WBD
LUMN
HOOD